Filing Flows › Apnimed (APMD) › Q2 2026
Apnimed (APMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Sep 8, 2026
Apnimed (APMD) reported revenue of $12.1M for the second quarter 2026 (Q2 2026), -29% from a year earlier. Operating margin was -96.9%.
Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.1M | — | -29% |
| Operating profit | −$11.7M | — | — |
| Net earnings | $126M | — | — |
What changed
Revenue was $12.1M in Q2 2026, down 29% year over year.
Operating costs exceeded revenue by $11.7M, an operating margin of -96.9%. Total costs grew 3% against a revenue fall of 29%. The fastest-growing cost line was General & admin (+137%). Net earnings were $125.9M. The effective tax rate was 0.0%. Non-operating items added $137.8M, 109% of pre-tax earnings, so the bottom line overstates operating performance.
Questions
What was Apnimed's revenue in the second quarter 2026?
Apnimed (APMD) reported revenue of $12.1M for the second quarter 2026 (Q2 2026), -29% from a year earlier.
Was Apnimed profitable in the second quarter 2026?
Operating loss was $11.7M (-96.9% of revenue) and net earnings $126M.
Source: Apnimed 10-Q on SEC EDGAR.